News
Podcast: Pharma – The Last Word
01 May 2024
Welcome to the podcast series, "Pharma: The last word," hosted by Partner Phil Katz. This series aims to dive into the intricate world of pharmaceuticals and biotech regulatory and legal...
News
01 May 2024
Welcome to the podcast series, "Pharma: The last word," hosted by Partner Phil Katz. This series aims to dive into the intricate world of pharmaceuticals and biotech regulatory and legal...
News
01 May 2024
Companies should review their resiliency, vendors, suppliers, and plans for partnering with the FBI in case of a cyber event, says FBI.
News
01 May 2024
A snapshot of key market and regulatory developments expected to impact the UK insurance sector over the next few months.
News
01 May 2024
On April 10, 2024, the U.S. Department of State’s Directorate of Defense Trade Controls (“DDTC”) published guidance for universities and research centers to comply with...
News
01 May 2024
On 30 April 2024, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) published its strategic approach to AI and the steps it is taking to implement the UK Government's AI ...
Insights and Analysis
01 May 2024
Our 10th annual M&A Year in Review features a 2024 M&A Outlook, which provides insights across the key topics that we expect will influence dealmaking in the months to come:...
News
30 April 2024
On 22 February 2024, Attorney-General (AG) Emiliou delivered an opinion in the BSH Hausgeräte/Electrolux case (C‑339/22). The opinion deals with the interpretation of Article 24(4) of...
News
30 April 2024
The EU is implementing new regulations to hold companies liable for human rights and environmental violations within the global supply chain. On 24 April 2024, the European Parliament...
News
30 April 2024
The European Parliament's recent approval of the AI Act entails a significant step in regulating artificial intelligence systems in the European Union. Among its pivotal provisions,...